Not applicableStudy completedNCT05216796What this trial is testingHealthy Liver - Healthy BrainWho this might be right forMetabolic SyndromeNon-Alcoholic Fatty Liver DiseaseNAFLD+1 more University of Texas at Austin 55
Not applicableEnrolling By InvitationNCT06895018What this trial is testingMedium-term Effects of a Polyphenol-rich Beverage Based on Red Grape Pomace Extract on Non-alcoholic Fatty Liver Disease, Cardiometabolic Risk Profile and Gut Microbiota in Subjects with Type 2 DiabetesWho this might be right forDiabetes Mellitus Type 2 Federico II University 20
Not applicableStudy completedNCT07622680What this trial is testingComparative Effects of Mediterranean and DASH Diet on Hepatic FunctionWho this might be right forNAFLD (Nonalcoholic Fatty Liver Disease)Hep A University of Lahore 75
Not applicableEnded earlyNCT04576923What this trial is testingQuantitative Ultrasound With Liver Incytes for Evaluation of Non-Alcoholic Fatty Liver DiseaseWho this might be right forNAFLDNASH - Nonalcoholic Steatohepatitis Indiana University 36
Early research (Phase 1)Study completedNCT04844450What this trial is testingA Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795Who this might be right forFatty Liver Disease Janssen Research & Development, LLC 55
Not applicableStudy completedNCT02907684What this trial is testingThe Impact of Almond Nut Consumption on Markers of CVD & Metabolic HealthWho this might be right forCardiovascular Disease King's College London 108
Post-approval studies (Phase 4)Study completedNCT02147925What this trial is testingEfficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM SubjectsWho this might be right forNon-alcoholic Fatty Liver Disease Sun Yat-sen University 75
Very early researchStudy completedNCT05737433What this trial is testingSingle Dose ADME Study of [14C]-Rencofilstat in Healthy Male SubjectsWho this might be right forNASH With Fibrosis Hepion Pharmaceuticals, Inc. 6
Not applicableNot Yet RecruitingNCT07455149What this trial is testingAn Observational Clinical Study on the Association of Intestinal Ruminococcus Gnavus and Its Derived Biogenic Amines With Metabolic Dysfunction-associated Fatty Liver DiseaseWho this might be right forMetabolic Dysfunction-associated Fatty Liver Disease Zhujiang Hospital 200
Not applicableNot Yet RecruitingNCT07053709What this trial is testingScreening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD)Who this might be right forHyperuricemia and MAFLD Assiut University 200
Not applicableUnknownNCT05880316What this trial is testingPrevalence of MAFLD Among Nurses and the Role of Intermittent FastingWho this might be right forFatty Liver Disease Universiti Kebangsaan Malaysia Medical Centre 100
Not applicableLooking for participantsNCT05618626What this trial is testingPrevention of NAFLD and CVD Through Lifestyle InterventionWho this might be right forNon-Alcoholic Fatty Liver DiseaseGallstone Disease Pontificia Universidad Catolica de Chile 300
Not applicableUnknownNCT03787108What this trial is testingMeasuring Fatty Liver With Ultrasound and MRS in Children With Overweight or ObesityWho this might be right forNon-Alcoholic Fatty Liver Disease Maastricht University Medical Center 53
Testing effectiveness (Phase 2)Study completedNCT04971785What this trial is testingStudy of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)Who this might be right forNonalcoholic Steatohepatitis Gilead Sciences 457
Large-scale testing (Phase 3)Study completedNCT01529268What this trial is testingCysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in ChildrenWho this might be right forNonalcoholic Fatty Liver Disease (NAFLD) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 169
Early research (Phase 1)Study completedNCT06024408What this trial is testingA Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk FactorWho this might be right forNonalcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis (NASH)Genetic Risk Factor Regeneron Pharmaceuticals 9
Not applicableStudy completedNCT06357052What this trial is testingThe Study of Lithogenesis Processes in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)Who this might be right forNAFLDUrinary Lithiasis Fondazione Policlinico Universitario Agostino Gemelli IRCCS 42
Early research (Phase 1)Ended earlyNCT03332940What this trial is testingSafety Evaluation of IV Tc 99m Tilmanocept and Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASHWho this might be right forNonalcoholic SteatohepatitisNASH - Nonalcoholic Steatohepatitis Navidea Biopharmaceuticals 6
Not applicableUnknownNCT06157125What this trial is testingAssessment of the Association Between Metabolic Associated Fatty Liver Disease (MFLD) and Biopsy Proved Cases of GNWho this might be right forAssessment of Patients With Biopsy Proven Primary Glomerulonephritis Above 18 Years of Age for MFLD Development Assiut University 100
Not applicableLooking for participantsNCT07149571What this trial is testingTo Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver DiseaseWho this might be right forNonalcoholic Fatty Liver DiseaseMetabolic-associated Fatty Liver Disease Tongji Hospital 500